1. Consent decree against Downing Labs: sterile products adulterated

   News item 23 January 2016 Pages: 1 - 1

2. Fingolimod: immunosuppressive effects linked to serious AEs?

   Correspondence 23 January 2016 Pages: 2 - 2

3. New recommendations for use of Viekirax ± Exviera in Ireland

   News item 23 January 2016 Pages: 3 - 3

4. Oral fluoroquinolones: risk of retinal detachment

   News item 23 January 2016 Pages: 4 - 4

5. PMDA releases investigation results for six primary drugs

   News item 23 January 2016 Pages: 5 - 5

6. Benefit−risk balance for Rotarix favourable in Japan

   Clinical study 23 January 2016 Pages: 6 - 6

7. Dosing errors common in dialysis patients in South Korea

   Clinical study 23 January 2016 Pages: 7 - 7

8. Inadequate contraception in adolescents prescribed teratogens

   Clinical study 23 January 2016 Pages: 8 - 8

9. MS risk with TNF-α inhibitors examined: Danish results

   Correspondence 23 January 2016 Pages: 9 - 9

10. Newly adjuvanted vaccines in children: no safety concerns

    Review 23 January 2016 Pages: 10 - 10

11. Pharmacists' interventions reduce costs, improve safety

    Clinical study 23 January 2016 Pages: 11 - 11

12. Proton pump inhibitors increase risk of CKD

    Clinical study 23 January 2016 Pages: 12 - 12

13. Acenocoumarol

    Case report 23 January 2016 Pages: 13 - 13

14. Adalimumab

    Case report 23 January 2016 Pages: 14 - 14

15. Adalimumab

    Case report 23 January 2016 Pages: 15 - 15

16. Adalimumab

    Case report 23 January 2016 Pages: 16 - 16

17. Adalimumab/infliximab

    Case report 23 January 2016 Pages: 17 - 17

18. Adalimumab/infliximab/tacrolimus

    Case report 23 January 2016 Pages: 18 - 18

19. Afatinib

    Case report 23 January 2016 Pages: 19 - 19

20. Aflibercept/fluorouracil/folinic acid/irinotecan

    Case report 23 January 2016 Pages: 20 - 20

21. Albendazole/ivermectin

    Case report 23 January 2016 Pages: 21 - 21

22. Alemtuzumab

    Case report 23 January 2016 Pages: 22 - 22

23. Alemtuzumab/chlorambucil/rituximab

    Case report 23 January 2016 Pages: 23 - 23

24. Alendronic acid

    Case report 23 January 2016 Pages: 24 - 24

25. Alendronic acid

    Case report 23 January 2016 Pages: 25 - 25

26. Alendronic-acid/Methotrexate

    Case report 23 January 2016 Pages: 26 - 26

27. Alteplase

    Case report 23 January 2016 Pages: 27 - 27

28. Amlodipine/aspirin/prednisone

    Case report 23 January 2016 Pages: 28 - 28

29. Amlodipine/carvedilol/lidocaine

    Case report 23 January 2016 Pages: 29 - 29

30. Anaesthetics

    Case report 23 January 2016 Pages: 30 - 30

31. Antiarrhythmics

    Case report 23 January 2016 Pages: 31 - 31

32. Antidepressants/clonazepam

    Case report 23 January 2016 Pages: 32 - 32

33. Antineoplastics

    Case report 23 January 2016 Pages: 33 - 33

34. Antineoplastics

    Case report 23 January 2016 Pages: 34 - 34

35. Antineoplastics

    Case report 23 January 2016 Pages: 35 - 35

36. Antithymocyte globulin/ciclosporin

    Case report 23 January 2016 Pages: 36 - 36

37. Aripiprazole

    Case report 23 January 2016 Pages: 37 - 37

38. Artesunate

    Case report 23 January 2016 Pages: 38 - 38

39. Aspirin

    Case report 23 January 2016 Pages: 39 - 39

40. Aspirin/clopidogrel

    Case report 23 January 2016 Pages: 40 - 40

41. Atorvastatin

    Case report 23 January 2016 Pages: 41 - 41

42. Axitinib

    Case report 23 January 2016 Pages: 42 - 42

43. Axitinib/bevacizumab/pazopanib

    Case report 23 January 2016 Pages: 43 - 43

44. Axitinib/sorafenib

    Case report 23 January 2016 Pages: 44 - 44

45. Azathioprine withdrawal

    Case report 23 January 2016 Pages: 45 - 45

46. Azathioprine/infliximab/prednisone

    Case report 23 January 2016 Pages: 46 - 46

47. Belimumab

    Case report 23 January 2016 Pages: 47 - 47

48. Benzydamine

    Case report 23 January 2016 Pages: 48 - 48

49. Benzylpenicillin/Epinephrine

    Case report 23 January 2016 Pages: 49 - 49

50. Betamethasone

    Case report 23 January 2016 Pages: 50 - 50